Article

Cataract surgery-induced dry eye may not be a direct consequence of surgery

Dry eye following cataract surgery may not be a direct result of the surgery but rather the surgery triggers symptoms in eyes with pre-existing sub-optimal tear properties.

Dry eye following cataract surgery may not be a direct result of the surgery but rather the surgery triggers symptoms in eyes with pre-existing sub-optimal tear properties, according to Waheeda Illahi and colleagues from BMEC, City Hospital, Birmingham, UK.

A study was conducted to assess tear quantity, break-up time and central corneal thickness following cataract surgery. Tear quantity was measured using a phenol red thread, fluorescein break-up time (measured in seconds) was quantified by standard biomicroscopy and central corneal thickness was measured by ultrasonic pachymetry after topical anaesthesia. Measurements were taken from right eyes in bilateral cases and age and gender matched controls.

The results showed that mean phenol red thread was 16.9 mm in the study group and 16.5 mm in the controls. Mean break-up time was 4.9 seconds in the study group and 4.6 seconds in the controls. Mean central corneal thickness was 541.2 µm in the study group and 539.0 µm in the controls. Comparisons revealed no statistical differences between the two groups but there was a significant correlation between break-up time and phenol red thread in the study group (r=0.265, p=0.028).

Although dry eye symptoms are often reported after cataract surgery, this study suggests that surgery is not the direct cause but rather that the surgery triggers symptoms in eyes with pre-existing sub-optimal tear properties.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.